1. Purulent Meningitis in Children Jiang Li Department of Neurology Children’s Hospital Chongqing University of Medical Sciences

2.  Acute infection of central nervous system(CNS). 90% of cases occur in the age of 1mo-5yr.  The inflammation of meninges caused by various bacteria.Common features in clinical practices include: fever, increased intracranial pressure, meningeal irritation.  One of the most potentially serious infections, associated with high mortality (about 10%) and morbidity. Purulent Meningitis

3. 1.Etiology 1.1 Pathogens:  Main pathogens: Neissria meningitidis, streptoccus pneumoniae, Haemophilus influenzae. (2/3 of purulent meningitis are caused by these pathogens)  Pathogens in special populations (neonate & <3mo infants, malnutrition, immunodeficiency): gramnegative enteric bacilli, group B streptococci, staphlococcus aureus

4. 1.2 Major risk factors for meningitis  Immature immunologic function and attenuated immunologic response to pathogens  Low level of immunoglobulin, defects of complement and properdin system  Immature or impaired blood-brain-barrier (BBB)  Immature BBB function: maturation at about 1yr  Impaired BBB: Congenial or acquired defects across mucocutaneous barrier

5. 1.3 Access of bacteria invasion  Typical access---hematogenous dissemination  Bacteria colonizing the mucous membranes of the nasopharynx  invasion into local tissue  bacteremia  hematogenous seeding to the subarachnoid space  Mode of transmission: Person to person contact through respiratory tract secretions or droplets

6.  Bacteria spread to the meninges directly: through anatomic defects in the skull or head trauma  Invasion from parameningeal organs: such as paranasal sinuses or middle ear Access of bacteria invasion

7. 2. Pathology  Structure of meninges

8.  Characterized by leptomeningeal and perivascular infiltration with polymorphonuclear leukocytes and an inflammatory exudate.  Exudate which may be distributed from convexity of brain to basal region of cranium.  Exudate is more thickness due to streptococcus pneumoniae than other pathogens. Pathology

9. 3. Clinical manifestations  The younger the child is, the higher incidence of meningitis will be. ½-2/3 of cases occur less than 1yr of age.  Mode of presentation:  Acute or fulminant onset: symptoms and signs of sepsis; meningitis evolve rapidly over a few hours and death within 24 hours; usually infected with Neissria meningitides (N. meningitides).

10.  Subacute onset: Precede by several days of upper respiratory tract or gastrointestinal symptoms; difficult to pinpoint the exact onset of meningitis; usually with meningitis due to Haemophilus influenzae (H influenzae) and streptoccus pneumococcus (S pneumococcus). Mode of presentation

11.  Common features of meningitis:  signs of systemic infection : fever(90-95%), anorexia,shock, alteration of mental status and consciousness  neurological signs:  increased intracranial pressure: headache, vomiting(82%), herniation  meningeal irritation: nuchal rigidity(77%), kernig sign, brudzinski sign Clinical manifestations

12. brudzinski sign

13.  Seizure (20-30%)  Focal or generalized  Due to cerebritis, infarction, electrolyte disturbances  Frequently noted with H influenzae & S pneumococcal meningitis  Persist after 4 th day and difficult to treat with poor prognosis Clinical manifestations

14.  Alteration of mental status and consciousness  Including: irritability, lethargy, stupor obtundation, coma  Due to increased intracranial pressure, cerebritis, hypotension  Often with pneumococcal or meningococcal meningitis  Comatose patients with a poor prognosis

15.  The symptoms and signs are not evident in neonates and infants younger than 3mo of age; and patients already received irregular antibiotic therapy. Clinical manifestations

16. Signs of systemic infection Increased intracranial pressure meningeal irritation Typical (older children) Fever, altered consciousness, seizure Headache, vomiting, herniation nuchal rigidity, back pain, kernig sign, brudzinski sign Atypical (neonate & <3mo infant ) Fever,normal temperature or hypothermia; minim or subtle seizure; poor feeding;less activity Scream,frown; bulging or full fontanel; widening of the sutures Not evident Comparison of the manifestations of meningitis between different age groups Clinical manifestations

17. 4. Diagnosis  Earlier diagnosis and prompt initiation of effective antibiotic treatment is critical for minimizing sequelae of purulent meningitis.  Suspected cases: febrile infants with seizure, meningeal irritability, increased intracranial pressure, altered mental status  Pay attention to the atypical symptoms and signs in neonate, infant and patient already received irregular antibiotic therapy

18.  Diagnosis is confirmed by analysis of cerebrospinal fluid ( CSF)  Suggestion bacterial meningitis  Increased pressure (90%)  Appearance: slightly cloudy to purulent  Raised white blood cells,consisting chiefly of polymorphonuclear leukocytes  Raised protein concentration, decreased glucose concentration (80%) Diagnosis

19.  Confirmation of the diagnosis: isolation from the CSF of a specific bacterial pathogen by microscopy or a positive culture or rapid antigen- detection test of CSF  Gram-stained smear of CSF: identify the causative organism in 70-90% of cases  CSF culture: positive in about 80% of cases. definitive diagnosis, determination of antibiotic sensitivity.  PCR: amplifies bacterial DNA (H influenzae, N. meningitidis) Diagnosis

20. 5. Differential diagnosis  Purulent meningitis caused by different pathogens  Neissria meningitidis:  Occur in epidemics (type A,C), which is more common in spring, or sporadic all the year (type B,C,Y)  Sudden onset with various cutaneous signs ( petechiae, purpura, or an erythematous macular rash)

21.  Streptococcus pneumoniae:  Young infants ( <1yr) are most susceptible population  Peak season: spring and winter  Easier to have subdural effusion and hydrocephalus  Easily have a protracted course and relapse Differential diagnosis

22.  Haemophilus influenzae  Occurs predominantly in infants 2mo to 2yr of age  Many cases are in winter  Higher incidence of subdural effusion  Others pathogens: staphylococcus aureus, gramnegative enteric bacilli  Special susceptible population: neonate, <3mo infants, malnutrition, immunodeficiency  Severe infection, difficult to treat Differential diagnosis

23.  Meningitis caused by other microorganisms Viral meningitis/encephalitis:  Viral meningitis/encephalitis:  Less severe systemic infectious symptoms  Less severe systemic infectious symptoms  Usually not develop after 2-3weeks  Usually not develop after 2-3weeks  CSF: normal glucose  CSF: normal glucose Differential diagnosis

24.  Tuberculous meningitis  Subacute onset and progress  Subacute onset and progress  A history of close contact with known  A history of close contact with known cases of tuberculosis cases of tuberculosis  Evidence of acute or healed tubercular  Evidence of acute or healed tubercular infection on chest x-ray infection on chest x-ray  Tuberculin skin test : OT, PPD  Tuberculin skin test : OT, PPD  CSF  CSF Differential diagnosis

25. DiseasePressure (Kpa) aspectTotal WBC (x10 6 /L) Protein (g/L) Glucose (mmol/L) smearscultures normal 0.69-1.96 (0.29- 0.78) clear0-5 (0-20) 0.2-0.4 (0.2-1.2) 2.2-4.4-- Purulent meningitis  cloudy  (PMN)  (1-5)  (<2.2) Gram’s stain + + Tuberculous meningitis  Normal or cloudy  (MN)  AFB stain +  Viral meningitis/ encephalitis Normal or  NormalNormal or  (MN) Normal or  (<1) normal-  Fungal meningitis Normal or  Normal or cloudy  (MN)  India ink prep +  Cerebrospinal fluid in neurologic infection

26. 6. Complications and sequelae 6.1 Subdural effusion  Definitive diagnosis: volume of fluid in subdural space >2ml, protein>0.4g/L,  Incidence: develop in 10-30% of patients, asymptomatic in 85-90% of patients; especially common in infants 4-6 month of age ( rare in children over 1yr);

27.  Causative organisms: 45% of cases of meningitis caused by H influenzae, 30% by S pneumoniae, 9% by N meningitidis subdural effusion

28.  Indications:  No response to a sensitive antibiotic therapy  Prolonged fever or fever reoccurring after an afebrile interval with effective treatment  Bulging fontanel, widening of sutures, enlarging head circumference, emesis,seizure, altered consciousness.  Improved CSF profile with more serious clinical manifestations subdural effusion

29.  Diagnosis methods:  Cranial translucent test  B ultrasonic examination and CT  Subdural space puncture subdural effusion normal subdural effusion

30. 6.2 Ventriculitis 6.3 hydrocephalus Complications

31. Circulation of cerebrospinal fluid(CSF)

32. 6.2 Ventriculitis  Usually occurs in neonates and infants (<1yr), with severe prognosis  The main cause is delayed diagnosis and treatment of meningitis. Complications

33.  Diagnosis:  B ultrasonic examination or neuroimaging studies( CT, MRI): enlarged lateral ventricle  Lateral ventricle puncture: bacteria and inflammatory cells in ventricular fluid, Glucose 50x10 6 /L, Glucose<1.6mmol/L, or protein>400mg/L. or protein>400mg/L. Ventriculitis

34. Circulation of cerebrospinal fluid(CSF)

35. 6.3 hydrocephalus :  Communicating hydrocephalus: adhered or destroyed arachnoid granulation around the cistern at the base of the brain  Obstructive hydrocephalus: following obstructed of the cerebral aqueduct, or the foramina of Magendie and Luschka 6.4 others: Deafness, blindness, paralysis, epilepsy, mental retardation Complications

36. 7. Treatment 7.1 Antibacterial therapy  Therapy principles: early treatment, antibiotics susceptible to pathogens and with high permeability through BBB, given intraveninously, enough dose, enough course of antibiotic therapy

37.  Susceptible to pathogens  First choice: Cefotaxime, Ceftriaxone (3dr generation of cephalosporins, high permeability through BBB, products of metabolism also has effect, CSF sterilization within 24h)  Other choice: Penicillin, Chloromycin, Cefuroxime, Ceftazidime ( delayed effect to make CSF sterile, high incidence of relapse and deafness) Antibacterial therapy

38. EtiologyStandard antibiotics of choiceDuration of therapy H.influenzaeCefotaxime /Ceftriaxone7-10days N.meningitidisCefotaxime /Ceftriaxone7days S.pneumoniaeCefotaxime /Ceftriaxone2-3weeks Staphlococcus aureus Semisynthetic penicillins (Oxacillin sodium, Cloxacillin sodium),Norvancomycin >3weeks E.coliCefotaxime /Ceftriaxone (or + ampicillin) > 3weeks UnknownCefotaxime/Ceftriaxone + ampicillin>2-3weeks Antibiotic therapy of bacterial meningitis

39.  Maintenance fluid and thermal energy supplement:  Fluid administration: 60-80ml/kg/day  Fluid infusion with dehydration therapy 7.2 Supportive care Treatment

40.  increased intracranial pressure  Osmotic therapy: intravenous mannitol 0.5- 1g/kg/every time, q4-6h  Combination with intravenous dexamethasone: 0.3-0.5mg/kg/day  Endotracheal intubation and hyperventilation Treatment

41.  Subdural effusion  Few volume could be absorbed with treatment spontaneously  Subdural puncture: take out 15ml/each time (unilateral puncture), less than 30ml/each time ( bilateral puncture), everyday or every other day  Stripping operation: for the cases not cure after 3-4weeks Treatment

42.  Others:  Ventriculitis : lateral ventricle puncture and injection of antibiotics locally  Epilepsy: AEDs Treatment